Inside information: Nightingale Health acquires worldwide license for blood self-collection device Velvet™
Inside information Company release, 31 January 2023 at 4:05 p.m. (EET) Nightingale Health Plc, a technology company promoting preventative health with its proprietary disease risk detection platform, has acquired a worldwide license and rights to blood self-collection device Velvet™ from Weavr Health Corp (“Weavr”). The acquired license gives Nightingale Health the rights to independently manufacture the Velvet™ devices and commercially use the devices in connection with Nightingale Health’s services. Nightingale Health will use the Velvet™ device in its preventative